198 related articles for article (PubMed ID: 32885368)
21. The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines.
Frank RG; Hicks A; Berndt ER
Med Care Res Rev; 2021 Oct; 78(5):585-590. PubMed ID: 32468959
[TBL] [Abstract][Full Text] [Related]
22. Differences in generic drug prices between the US and Canada.
Gooi M; Bell CM
Appl Health Econ Health Policy; 2008; 6(1):19-26. PubMed ID: 18774867
[TBL] [Abstract][Full Text] [Related]
23. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
Wineinger NE; Zhang Y; Topol EJ
JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
[TBL] [Abstract][Full Text] [Related]
24. Comparison of United States and canadian glaucoma medication costs and price change from 2006 to 2013.
Schlenker MB; Trope GE; Buys YM
J Ophthalmol; 2015; 2015():547960. PubMed ID: 25922760
[TBL] [Abstract][Full Text] [Related]
25. Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology.
Sharma A; Rorden L; Ewen M; Laing R
J Pharm Policy Pract; 2016; 9():12. PubMed ID: 27054040
[TBL] [Abstract][Full Text] [Related]
26. Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell Lung Cancer in the US From 2015 to 2020.
Desai A; Scheckel C; Jensen CJ; Orme J; Williams C; Shah N; Leventakos K; Adjei AA
JAMA Netw Open; 2022 Jan; 5(1):e2144923. PubMed ID: 35076701
[TBL] [Abstract][Full Text] [Related]
27. Analyzing Access and Costs of Oral Medications for Overactive Bladder: Uncovering Disparities.
Shapiro K; Dusetzina SB; Brucker BM; Escobar CM
Urology; 2024 Jan; 183():57-62. PubMed ID: 37778479
[TBL] [Abstract][Full Text] [Related]
28. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
[TBL] [Abstract][Full Text] [Related]
29. Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.
Clemans-Cope L; Epstein M; Banthin J; Kesselheim AS; Hwang TJ
JAMA Health Forum; 2023 Jan; 4(1):e225012. PubMed ID: 36637815
[TBL] [Abstract][Full Text] [Related]
30. Do higher-priced generic medicines enjoy a competitive advantage under reference pricing?
Puig-Junoy J
Appl Health Econ Health Policy; 2012 Nov; 10(6):441-51. PubMed ID: 22900924
[TBL] [Abstract][Full Text] [Related]
31. Do generics offer significant savings to the UK National Health Service?
Kanavos P
Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
[TBL] [Abstract][Full Text] [Related]
32. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
[TBL] [Abstract][Full Text] [Related]
33. Trends in price for topical corticosteroids from 2017 to 2021 and the opportunity for cost savings identifiable at the point of care: A retrospective cross-sectional study.
Kwa M; Guttentag A; Chase L; van Meijgaard J; Lim HW
J Am Acad Dermatol; 2024 Jan; 90(1):74-81. PubMed ID: 37730020
[TBL] [Abstract][Full Text] [Related]
34. Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications.
Shah AA; Kumar P; Ogunmola AG; Ayyash O; Yabes JG; Sabik LM; Odisho AY; Bandari J; Macleod LC; Davies BJ; Jacobs BL
Urology; 2021 Feb; 148():224-229. PubMed ID: 32961225
[TBL] [Abstract][Full Text] [Related]
35. State prescription drug price Web sites: how useful to consumers?
Tu HT; Corey CG
Res Brief; 2008 Feb; (1):1-16. PubMed ID: 18494180
[TBL] [Abstract][Full Text] [Related]
36. Medicare-approved drug discount cards and prescription drug prices.
Chisholm MA; Turner JC; Dipiro JT
Am J Health Syst Pharm; 2005 Jul; 62(14):1482-7. PubMed ID: 15998928
[TBL] [Abstract][Full Text] [Related]
37. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
Murry L; Gerleman B; Urick B; Urmie J
J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
[TBL] [Abstract][Full Text] [Related]
38. Generic script share and the price of brand-name drugs: the role of consumer choice.
Rizzo JA; Zeckhauser R
Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220
[TBL] [Abstract][Full Text] [Related]
39. Patient Awareness of Local Drug Price Variation and the Factors That Influence Pharmacy Choice: A Cross-sectional Survey Study.
Brodsky SD; Awosika OD; Eleryan MG; Rengifo-Pardo M; Kuang X; Amdur RL; Ehrlich A
J Drugs Dermatol; 2017 Dec; 16(12):1274-1280. PubMed ID: 29240864
[TBL] [Abstract][Full Text] [Related]
40. A comparison of brand-name drug prices between Canadian-based Internet pharmacies and major U.S. drug chain pharmacies.
Quon BS; Firszt R; Eisenberg MJ
Ann Intern Med; 2005 Sep; 143(6):397-403. PubMed ID: 16172438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
